TRVN: Total Utang marang Modal Trevena
Trevena, Inc. (TRVN) is currently in a lull due to low demand for the drug Olinvyk, forcing management to implement strict cost-cutting measures. This price chart reflects a debt-to-equity ratio of 0.00. The company develops unique CNS treatments using the biased ligand method to combat pain without the risk of addiction. However, leadership at this micro-cap biotech is facing a capital shortage and regulatory challenges.
%20-%20Utang%20marang%20Modal&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_TRVN_-_Trevena-Inc._-_Debt-to-Capital "Rasio Total Utang marang Ekuitas: Trevena, Inc. (TRVN) kanggo 04.07.2022 - 19.10.2024 | 👁️GURU.Markets👁️")
Rincian metrik lan analitis perusahaan Trevena Inc (TRVN)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Trevena, Inc.|TRVN - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Trevena, Inc.|TRVN - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Trevena|TRVN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Trevena|Indikator likuiditas cepet trevena.com
- statistik bathi lan rasio pasar:
Pambiji fundamental:TRVN, Trevena
The virtual model of Trevena, Inc. (TRVN), which delegates trials to external CROs, minimizes capital expenditures, directly impacting the balance sheet structure. By analyzing changes in the debt-to-equity ratio, investors assess the proportion of total liabilities relative to shareholders' equity: a decrease in this ratio confirms crisis resilience, whereas an increase signals heightened debt leverage and credit risks.
Analisis pesaing Trevena, Inc.
Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Rasio Total Utang marang Ekuitas HRMY|BHVN (biohavenpharma.com) - Utang Agregat marang Modal|Utang marang Ekuitas Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRAX (Praxis Medicines)|Anavex Life Sciences Corp (AVXL) - Utang marang Modal|CBLL: Rasio Total Utang marang Ekuitas|PRTA: Utang marang Ekuitas|ALEC: Total Utang marang Modal|Utang marang Modal Annexon Biosciences (ANNX)|Utang marang Ekuitas Omeros Corp|Rasio Utang marang Ekuitas NGNE (Neurogene Therapeutics)|Total Utang marang Modal ACIU|Total Utang marang Modal voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SCLX|Tevogen Bio Holdings, Inc. - Total Utang marang Modal|Koefisien Total Utang marang Modal Alpha Cognition ACOG|Cognition Therapeutics (CGTX) - Utang marang Ekuitas|Rasio Utang marang Ekuitas IKT|SAVA (Cassava Sciences) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Assertio Therapeutics (ASRT)|Rasio Total Utang marang Ekuitas COYA (Coya Therapeutics, Inc.)|Koefisien Total Utang marang Modal vistagen.com|Ovid Therapeutics - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal ABOS (acumenpharm.com)|CRVO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ATHE (Alterity Therapeutics)|CLNN (clene.com) - Rasio Total Utang marang Ekuitas|PEPG (PepGen) - Utang marang Ekuitas|Utang marang Ekuitas Jupiter Neurosciences Inc|Rasio Utang marang Ekuitas RLMD (relmada.com)|Utang marang Ekuitas Annovis Bio (ANVS)|gracetx.com - Rasio Utang marang Ekuitas|Total Utang marang Modal AIFF (Firefly Neuroscience Inc)|ANEW Medical (KLTO) - Utang marang Modal|NRSN: Rasio Total Utang marang Ekuitas|RVPH - Total Utang marang Modal|metaviatx.com (MTVA) - Utang marang Ekuitas|NeurAxis Inc. - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Helius Medical Technologies, Inc.|Utang marang Modal Passage Bio Corp PASG|Rasio Total Utang marang Ekuitas NEUP (Neuphoria Therapeutics Inc.)|Utang Agregat marang Modal NERV|Utang marang Ekuitas Athira Pharma ATHA|Rasio Kabeh Utang marang Dana Pribadi ADXN|Alzamend - Total Utang marang Modal|Utang marang Modal Cyclerion Therapeutics|PTIX (protagenic.com) - Rasio Total Utang marang Ekuitas|KTTA (Pasithea Therapeutics Corp.) - Utang marang Ekuitas|CRGT (Cortigent Inc) - Total Utang marang Modal|Utang marang Modal Avenue Therapeutics Inc. ATXI|Utang marang Ekuitas Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Rasio Utang marang Ekuitas|Total Utang marang Modal CHRO (Chromocell Therapeutics)|Total Utang marang Modal Eliem Therapeutics, Inc. ELYM|ITCI: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LBPH (Longboard Pharmaceuticals Inc)|MRNS: Total Utang marang Modal|NKGN - Koefisien Total Utang marang Modal|Utang marang Ekuitas NeuroBo Pharmaceuticals|Rasio Utang marang Ekuitas SAGE (sagerx.com)|Total Utang marang Modal SNPX|Rasio Total Utang marang Ekuitas vigilneuro.com VIGL|Anew Medical - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Cerevel Corp (CERE)